Key result
Monocyte/HDL-cholesterol ratio positively correlates with C-reactive protein in ambulatory chronic heart failure patients.
Why the study?
The monocyte/HDL-cholesterol ratio is a marker of inflammation, prompting investigation into its utility as a measure of severity in heart failure, an inflammation-associated condition.
Is the monocyte/HDL-cholesterol ratio associated with measures of severity in ambulatory patients with chronic heart failure?
Observational (n=323)
Is the monocyte/HDL-cholesterol ratio associated with measures of severity in ambulatory patients with chronic heart failure?
Answers are grounded in this paper and cite their sources.
The monocyte/HDL-cholesterol ratio may serve as a marker of inflammation and severity in patients with chronic heart failure.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Çattık et al. (2025) conducted an observational in Chronic heart failure (n=323). Monocyte/HDL-cholesterol ratio (MHR) was evaluated on Correlation with C-reactive protein (r: 0.312). The monocyte/HDL-cholesterol ratio (MHR) correlated positively with C-reactive protein (r: 0.312) in ambulatory patients with chronic heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: